Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Characteristics of subgroups based on the quartile of hs-CRP

From: The association between high-sensitivity C-reactive protein at admission and progressive motor deficits in patients with penetrating artery infarctions

Variabletotal (n = 544)quartile 1 (n = 136)quartile 2 (n = 136)quartile 3 (n = 136)quartile 4 (n = 136)P
Demographic characteristics
 Age, years65.4 ± 11.865.0 ± 10.365.8 ± 12.063.8 ± 11.666.9 ± 13.00.169
 Male, %387 (71.1)94(69.1)103(75.7)88(64.7)102(75.0)0.145
Vascular risk factors, %
 Hypertension360 (66.2)93 (68.4)90 (66.2)91 (66.9)86 (63.2)0.836
 Diabetes mellitus161 (29.6)36 (26.5)36 (26.5)40 (29.4)49 (36.0)0.243
 Dyslipidemia91 (16.7)25 (18.4)21 (15.4)22 (16.2)23 (16.9)0.927
 Current smoking221 (40.6)55 (40.4)63 (46.3)47 (34.6)56 (41.2)0.270
 Current drinking162(29.8)47 (34.6)44 (32.6)33 (24.3)38 (27.9)0.545
 Previous stroke67 (12.3)18 (13.2)16 (11.8)22 (16.2)11 (8.1)0.234
 Peripheral artery disease16 (2.9)3 (2.2)3 (2.2)4 (2.9)6 (4.4)0.672
 Coronary artery disease66 (12.1)18 (13.2)19 (14.0)15 (11.0)14 (10.3)0.760
Clinical data
 Previous antiplatelet, %57 (10.5)13 (9.6)14 (10.3)17 (12.5)13 (9.6)0.839
 Previous statin, %16 (2.9)5 (3.7)4 (2.9)5 (3.7)2 (1.5)0.627
 SBP, mmHg144.6 ± 20.6145.0 ± 19.0143.1 ± 21.3143.6 ± 20.5146.8 ± 21.70.465
 DBP, mmHg85.8 ± 12.385.5 ± 12.384.5 ± 12.586.6 ± 11.886.5 ± 12.70.478
 Body mass index, kg/m224.5 ± 3.524.1 ± 3.724.1 ± 3.024.9 ± 3.224.8 ± 3.90.145
 Initial totaol NIHSS, score2 (2–4)2 (1–4)2 (2–4)2 (1–4)3 (2–4)0.631
 White matter lesions, %354 (65.1)94 (69.1)85 (62.5)88 (64.7)87 (64.0)0.692
 Intravenous thrombolysis, %91 (16.7)19 (14.0)22 (16.2)24 (17.6)26 (19.1)0.703
 PMD, %85 (15.6)7 (5.1)3 (2.2)30 (22.1)45 (33.1)< 0.001
 MCA stenosis, %
  0307 (56.4)83 (61.0)74 (54.4)73 (53.7)77 (56.6)0.611
  ≤ 50%208 (38.2)48 (35.3)54 (39.7)54 (39.7)52 (38.2)0.862
  >50%29 (5.3)5 (3.7)8 (5.9)9 (6.6)7 (5.1)0.735
 VBA stenosis, %
  0302 (55.5)80 (58.8)71 (52.2)73 (53.7)78 (57.4)0.664
  ≤ 50%203 (37.3)48 (35.3)56 (41.2)51 (37.5)48 (35.3)0.719
  >50%39 (7.2)8 (5.9)9 (6.6)12 (8.8)10 (7.4)0.809
 Carotid artery atheromatosis, %
  Absence222 (40.8)46 (33.8)59 (43.4)62 (45.6)55 (40.4)0.220
  Moderate278 (51.1)76 (55.9)69 (50.7)62 (45.6)71 (52.2)0.369
  Significant44 (8.1)14 (10.3)8 (5.9)12 (8.8)10 (7.4)0.577
 Silent lacunar infarcts, %246 (45.2)63 (46.3)56 (41.2)62 (45.6)65 (47.8)0.721
 OMT, day2 (1,2)2 (1,2)2 (1,3)2 (1,2)2 (1,2)0.417
 Antibiotic use, %115 (21.1)23 (16.9)32 (23.5)24 (17.6)36 (26.5)0.155
Laboratory data
 Leukocyte number, 10^98.4 ± 4.18.2 ± 2.78.2 ± 3.08.4 ± 2.68.8 ± 6.60.562
 TC, mmol/L4.5 ± 1.04.3 ± 1.04.5 ± 1.14.5 ± 1.04.4 ± 1.00.313
 TG, mmol/L1.8 ± 1.21.5 ± 0.81.8 ± 1.31.9 ± 1.41.8 ± 1.10.065
 HDL, mmol/L1.1 ± 0.31.1 ± 0.51.1 ± 0.21.0 ± 0.21.1 ± 0.30.103
 LDL, mmol/L2.7 ± 0.82.8 ± 0.82.8 ± 0.92.8 ± 0.82.7 ± 0.90.504
 FBG, mmol/L6.0 ± 2.55.8 ± 2.25.7 ± 2.36.3 ± 2.76.2 ± 2.60.184
 Glycated hemoglobin, %6.4 ± 1.66.3 ± 1.46.3 ± 1.46.6 ± 1.76.6 ± 1.70.082
 Homocysteine, umol/L16.0 ± 8.214.6 ± 6.016.9 ± 10.015.8 ± 7.516.9 ± 8.70.076
  1. Abbreviations: SBP, Systolic blood pressure; DBP, Diastolic blood pressure; National Institutes of Health Stroke Scale; MCA, Middle cerebral artery; VBA, Vertebro-basilar artery; OMT, Onset to the measurement of hs-CRP time;TC, Total cholesterol; TG, Triglyceride; HDL, High density lipoprotein; LDL, Low density lipoprotein; FBG, Fast blood glucose
  2. ‘Antibiotic use’ means ‘the antibiotic use during hospitalisation’